Skip to main content

Table 3 Secondary outcomes

From: A pilot feasibility study of gabapentin for managing pain in children with dystonic cerebral palsy

Outcome measure

BaselineMean (SD)

6 weeksMean (SD)

12 weeksMean (SD)

Difference from baseline at 12 weeksMean 95 % (CI)

COPM performance

3.6 (0.9) N = 12

Not collected

7.0 (1.4) N = 11

3.5 (2.3, 4.6)

COPM satisfaction

2.2 (0.9) N = 12

Not collected

7.2 (2.6) N = 11

4.8 (3.1, 6.6)

BADS

23.8 (4.3) N = 12

20.9 (6.4) N = 10

21.9 (3.8) N = 10

-1.4 (-3.6, 0.8)

FPS-R

2.8 (1.4) N = 12

1.5 (1.3) N = 12

1.0 (1.3) N = 10

-1.8 (-3.1, -0.5)

CPCHILD

 Personal care

36.7 (20.3) N = 13

52.9 (22.3) N = 7

49.4 (18.2) N = 11

10.3 (2.0, 18.6)

 Positioning/transferring/mobility

38.8 (19.7) N = 13

53.0 (16.8) N = 7

51.4 (17.9) N = 11

8.3 (-4.9, 21.6)

 Comfort & emotions

62.4 (23.4) N = 13

78.9 (14.8) N = 7

81.2 (12.4) N = 11

11.1 (1.5, 20.8)

 Communication/social interaction

54.6 (17.0) N = 13

72.1 (16.7) N = 7

70.0 (14.3) N-11

13.0 (2.6, 23.4)

 Health

64.6 (17.7) N = 13

60.0 (13.9) N = 7

73.9 (11.7) N = 11

6.7 (-2.7, 16.1)

 Overall QoL

67.7 (27.7) N = 13

80.0 (17.9) N = 7

70.9 (16.4) N = 11

0.0 (-6.0, 6.0)

 Total

54.1 (16.6) N = 13

65.5 (14.0) N = 7

66.1 (11.7) N = 11

8.2 (0.9, 15.6)

CCHQ

 Personal care

4.1 (1.2) N = 13

2.6 (1.5) N = 6

3.2 (1.3) N = 11

-0.8 (-1.7, 0.10)

 Positioning/transferring

3.9 (1.6) N = 13

2.3 (1.3) N = 6

2.5 (1.1) N = 11

-1.1 (-2.2, -0.10)

Comfort

3.6 (1.2) N = 13

2.7 (1.4) N = 6

2.5 (1.5) N = 11

-0.9 (-1.6, -0.20)

 Interaction/communication

3.3 (1.1) N = 13

2.5 (0.9) N = 6

2.8 (1.1) N = 11

-0.5 (-0.9, -0.10)

  1. SD Standard Deviation, CI Confidence interval, COPM Canadian Occupational Performance Measure, BADS Barry Albright Dystonia Scale, FPS-R Face Pain Scale- revised, CPCHILD Caregiver Priorities & Child Health Index of Life with Disabilities, CCHQ Care and Comfort Hypertonicity Questionnaire